In addition, Tohumeken et al. reported that AML-derived EVs can induce conventional monocytes to differentiate into MDSCs, obtain a CD14+HLADRlow phenotype, and upregulate IDO to inhibit effector T-cell immunity. This evidence concerns the gene IDO1 and acute myeloid leukemia.